GGrantIndex
Sort

21,453 grants matching tuberculosis

Human Subjects Core

$119,513
Megan Murray · Brigham And Women'S Hospital · U19 · FY2021 · AI

Hair Cell Responses to Ototoxic Drugs

$119,310
Peter S Steyger · Creighton University · R01 · FY2019 · DC

RECOMBINOGENIC ENGINEERING OF PATHOGENIC BACTERIA

$119,250
Univ Of Massachusetts Med Sch Worcester · R21 · FY2003 · GM

Mentoring Investigators in HIV and Tuberculosis Therapeutics Research

$119,225
Kelly E. Dooley · Vanderbilt University Medical Center · K24 · FY2025 · AI

Mentoring Investigators in HIV and Tuberculosis Therapeutics Research

$119,225
Kelly E. Dooley · Vanderbilt University Medical Center · K24 · FY2024 · AI

Chemical Synthesis Core C

$119,110
Adriaan Minnaard · Brigham And Women'S Hospital · U19 · FY2021 · AI

OREGON TUBERCULOSIS CONTROL AND ELIMINATION

$119,079
Veda M Latin · Public Health Services · U52 · FY2015 · PS

GENETIC ANALYSIS OF LEGIONELLA PHAGOSOME TRAFFICKING

$119,028
Yale University · R29 · FY2001 · AI

Research Program: Immunology and Vaccine Development

$119,013
Philip D Greenberg · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA

Pharmacokinetics and immunodynamics of multimodal nanoparticles for HIV and TB

$119,000
Jessica L Reynolds · State University Of New York At Buffalo · R56 · FY2014 · AI

MTB directly regulates human CD4+ T cell activation

$118,976
Christina Louise Lancioni · Oregon Health & Science University · K08 · FY2010 · AI

Pilot Project

$118,910
Sora Park Tanjasiri · California State University Fullerton · U54 · FY2014 · CA

RECOMBINOGENIC ENGINEERING OF PATHOGENIC BACTERIA

$118,876
Univ Of Massachusetts Med Sch Worcester · R21 · FY2002 · GM

CELL CULTURE CORE FACILITY

$118,757
Renato J Aguilera · University Of Texas El Paso · G12 · FY2009 · RR

Emory-Georgia TB Research Training Program

$118,750
Henry M Blumberg · Emory University · D43 · FY2006 · TW

Clinical Core

$118,611
Christopher C. Whalen · Rutgers Biomedical And Health Sciences · U19 · FY2025 · AI

Tri-Institutional TB Research Unit: Persistence and Latency

$118,513
Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI

Viable but Nonculturable Mtb

$118,513
Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI

Repurposing antimalarials for the treatment of NTM infections

$118,512
Mary Jackson · Colorado State University · R01 · FY2024 · AI

Measure the metabolic and genetic factors that determine M. Tuberculosis

$118,501
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2015 · AI

Ethanol-fed, CpG-treated mice: Listeria susceptibility

$118,368
University Of Iowa · K01 · FY2003 · AA

MHC Typing Core

$118,356
Jeffrey A Roberts · University Of California At Davis · U42 · FY2025 · OD

Post-Tuberculosis Lung Disease in Youth with and without HIV Globally

$118,319
Leslie Anne Enane · Indiana University Indianapolis · R01 · FY2025 · AI

Toll-Like Receptors in Bacterial Antigen Induced HIV-LTR

$118,152
Cedars-Sinai Medical Center · K08 · FY2004 · AI

Toll-Like Receptors in Bacterial Antigen Induced HIV-LTR

$118,152
Cedars-Sinai Medical Center · K08 · FY2002 · AI